Clinical Trials Browser

Phase 1/2 × Bumetanide × 90 days × Clear all

NCT03107416 2026-05-05

Delivering a Diuretic Into the Liver Artery Followed by Plugging up the Artery to Starve Out Liver Cancer Cells

Phase 1/2 Active not recruiting

Gastrointestinal

Unresectable Hepatocellular Carcinoma